These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3149632)

  • 21. Ticarcillin-tobramycin-rifampin: in vitro synergy of the triplet combination against Pseudomonas aeruginosa.
    Zuravleff JJ; Yu VL; Yee RB
    J Lab Clin Med; 1983 Jun; 101(6):896-902. PubMed ID: 6406628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Susceptibility of Pseudomonas aeruginosa to aztreonam in comparison to other pseudomonas-active beta-lactam antibiotics and gentamicin].
    Wundt W; Lange KP; Baumgärtner M
    Arzneimittelforschung; 1985; 35(8):1322-5. PubMed ID: 3935123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative bactericidal activity of beta-lactam-aminoglycoside combinations against Pseudomonas aeruginosa].
    Cluzel M; Chanal M; Sirot J; Cluzel R
    Nouv Presse Med; 1982 Nov; 11(46):3400-4. PubMed ID: 6818523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the bactericidal activity of ciprofloxacin alone and in combination with selected antipseudomonal beta-lactam agents against clinical isolates of Pseudomonas aeruginosa.
    Stratton CW; Franke JJ; Weeks LS; Manion FA
    Diagn Microbiol Infect Dis; 1988 Sep; 11(1):41-52. PubMed ID: 3146458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.
    Burgess DS; Frei CR
    J Antimicrob Chemother; 2005 Nov; 56(5):893-8. PubMed ID: 16162664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Susceptibility of 100 blood isolates of Pseudomonas aeruginosa to 19 antipseudomonal antibiotics: old and new.
    Korvick J; Yu VL; Hilf M
    Diagn Microbiol Infect Dis; 1987 Jun; 7(2):107-11. PubMed ID: 3115670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibiotic susceptibility and mechanisms of beta-lactam resistance in 1310 strains of pseudomonas aeruginosa: a French multicentre study (1996).
    Cavallo JD; Fabre R; Leblanc F; Nicolas-Chanoine MH; Thabaut A;
    J Antimicrob Chemother; 2000 Jul; 46(1):133-6. PubMed ID: 10882703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro comparison of cefpirome and four other beta-lactam antibiotics alone and in combination with tobramycin against clinical isolates of Pseudomonas aeruginosa.
    Cabezudo I; Pfaller M; Bale M; Wenzel R
    Diagn Microbiol Infect Dis; 1989; 12(4):337-41. PubMed ID: 2512048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial Effects of β-Lactams on Imipenem-Resistant Ceftazidime-Susceptible Pseudomonas aeruginosa.
    Wi YM; Choi JY; Lee JY; Kang CI; Chung DR; Peck KR; Song JH; Ko KS
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pseudomonas aeruginosa: bactericidal activity on various beta-lactam resistance phenotypes of 8 antibiotics and 7 combinations].
    Dubrous P; Cavallo JD; Hernandez E; Nordmann P; Fabre R
    Pathol Biol (Paris); 1997 May; 45(5):433-7. PubMed ID: 9296099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic activity of aminoglycoside-beta-lactam combinations against Pseudomonas aeruginosa with an unusual aminoglycoside antibiogram.
    Clark RB; Pakiz CB; Hostetter MK
    Med Microbiol Immunol; 1990; 179(2):77-86. PubMed ID: 2113159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Influence of the inoculum effect on the MIC and MBC of 5 beta-lactams against Pseudomonas aeruginosa].
    Croize J; Le Noc P; Robert J
    Pathol Biol (Paris); 1984 May; 32(5):412-4. PubMed ID: 6429613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro synergy studies with ciprofloxacin and selected beta-lactam agents and aminoglycosides against multidrug-resistant Pseudomonas aeruginosa.
    Meyer RD; Liu S
    Diagn Microbiol Infect Dis; 1988 Nov; 11(3):151-7. PubMed ID: 3149927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Latamoxef in combination with aminoglycosides against Pseudomonas aeruginosa: similarity with ticarcillin.
    Sears SD; Tatem BA; Standiford HC
    Chemotherapy; 1985; 31(2):102-11. PubMed ID: 3921317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of beta-lactams in counter-selecting resistance of Pseudomonas aeruginosa.
    Tam VH; Schilling AN; Melnick DA; Coyle EA
    Diagn Microbiol Infect Dis; 2005 Jun; 52(2):145-51. PubMed ID: 15964503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activities of piperacillin, ceftazidime, cefepime and cefpirome against Pseudomonas aeruginosa strains with intrinsic ticarcillin resistance.
    Bert F; Setbon PG; Lambert-Zechovsky N; Branger C
    Chemotherapy; 1996; 42(6):426-31. PubMed ID: 8957576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with multiresistant strains of Pseudomonas aeruginosa.
    Lang BJ; Aaron SD; Ferris W; Hebert PC; MacDonald NE
    Am J Respir Crit Care Med; 2000 Dec; 162(6):2241-5. PubMed ID: 11112146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparison of the activity of beta-lactams against Pseudomonas aeruginosa according to phenotypes of resistance].
    Bert F; Briaud I; Branger C; Lambert-Zechovsky N
    Pathol Biol (Paris); 1996 May; 44(5):329-32. PubMed ID: 8758469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pseudomonas aeruginosa: in vitro susceptibility to antimicrobial drugs, single and combined, with and without defibrinated human blood.
    Traub WH; Spohr M; Bauer D
    Chemotherapy; 1988; 34(4):284-97. PubMed ID: 3145172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative activity of beta-lactam antibiotics against 'intrinsically' ticarcillin-resistant strains of Pseudomonas aeruginosa.
    Bert F; Bruneau B; Lambert-Zechovsky N; Branger C
    Chemotherapy; 1994; 40(3):183-7. PubMed ID: 8205936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.